Navigation Links
China Pharma Holdings, Inc. to Host Second Quarter 2008 Earnings Conference Call at 10 a.m. EDT Wednesday August 6, 2008
Date:8/1/2008

NEW YORK and HAIKOU, China, Aug. 1 /Xinhua-PRNewswire-FirstCall/ -- China Pharma Holdings, Inc. (''China Pharma'') (OTC Bulletin Board: CPHI) which develops, manufactures, and markets leading off-patent brand and newly developed products in China, today announced the Company will host an earning conference call at 10:00 a.m. EDT on Wednesday, August 6, 2008 to discuss these results. The Company also plans to release its earnings earlier that same day.

Ms. Zhilin Li, President and CEO of China Pharma Holdings, Inc., Mr. Xinhua Wu, Chief Financial Officer, and Mr. Alan Sheinwald, Partner of HC International will be hosting the call. To participate in the conference call, please dial 1-800-591-6945 ten minutes prior to the scheduled conference call time. International callers should dial 1-617-614-4911. The conference pass code is 11374834.

If you are unable to participate in the call at this time, a replay will be available on Wednesday, August 6 at 12:00 p.m. EDT, through Wednesday, August 13. To access the replay, please dial 1-888-286-8010. International callers should dial 1-617-801-6888. The conference pass code is 77875355. This conference call will be broadcast live over the Internet and can be accessed by clicking this link: http://phx.corporate-ir.net/playerlink.zhtml?c=145098&s=wm&e=1914439 . A replay will also be available shortly after the call on China Pharma' website http://www.chinapharmaholdings.com .

About China Pharma Holdings, Inc.

China Pharma Holdings, Inc. develops, manufactures, and markets leading off-patend brand and newly developed products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular, cerebrovascular, CNS, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd (Helpson), a specialty pharm
'/>"/>

SOURCE China Pharma Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. China Biologic Products Establishes Audit Committee and Appoints Three New Independent Directors to Board of Directors
2. Global Stem Cell Forum in China Showcases Cutting Edge Research, Focuses on New Findings for iPS Cells
3. China Medical Technologies Adjusts Conversion Rate of Convertible Notes
4. China-Biotics, Inc. Files Application for Nasdaq Listing
5. China Biologic Products Honored with the Advanced Technology Certification for Foreign-Funded Enterprises
6. China-Biotics, Inc. Announces Appointment of New Transfer Agent Effective August 15, 2008
7. China-Biotics, Inc. Reports Fourth Quarter and Full Year Fiscal 2008 Financial Results
8. WuXi PharmaTech (NYSE: WX) Named the Most Innovative Company in China and CEO Dr. Li the Most Innovative Leader of Chinese Enterprises
9. China Biologic Products Begins Operation of its Newly Constructed Plasma Collection Station in Qi He County, Shandong Province
10. China Agritech to Export Products to Egypt
11. China-Biotics, Inc. to Present at Chinas 3rd Annual Food Safety Technology Forum 2008
Post Your Comments:
*Name:
*Comment:
*Email: